Insider Buying: Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) President Purchases 3,510 Shares of Stock

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) President Amir F. Heshmatpour acquired 3,510 shares of the business’s stock in a transaction on Friday, May 16th. The shares were bought at an average cost of $16.87 per share, for a total transaction of $59,213.70. Following the acquisition, the president now owns 1,760,000 shares of the company’s stock, valued at $29,691,200. This represents a 0.20% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Neonc Technologies Price Performance

NTHI stock opened at $7.43 on Tuesday. Neonc Technologies Holdings, Inc. has a twelve month low of $4.11 and a twelve month high of $25.00.

Neonc Technologies (NASDAQ:NTHI) last released its quarterly earnings data on Friday, May 9th. The company reported ($2.10) earnings per share for the quarter. The business had revenue of $0.04 million for the quarter.

Institutional Trading of Neonc Technologies

A hedge fund recently bought a new stake in Neonc Technologies stock. Royal Bank of Canada bought a new stake in Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 18,525 shares of the company’s stock, valued at approximately $247,000.

About Neonc Technologies

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing.